Jnana Therapeutics scores $50 mln Series A
Boston-based Jnana Therapeutics Inc, which is focused on discovering drugs for cancer and other conditions by zeroing in on cellular proteins, has raised $50 million in Series A financing. The investors were Polaris Partners, Avalon Ventures, Versant Ventures, AbbVie Ventures and Pfizer R&D Innovate.
15 December 2017•1 min read
